Summary

Global Urinalysis Market is valued approximately at USD 3.3 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 7.2% over the forecast period 2021-2027. A urinalysis is used to detect and treat a variety of diseases and conditions, including kidney disease, urinary tract infections, and diabetes. Urinalysis is a chemical, physical, and microscopical analysis of urine to detect the presence of medicines or illnesses. Urinalysis and Sediment Urinalysis are the two forms of urinalysis. The concentration, appearance, and substance of urine are all checked during a urinalysis. Abnormal urinalysis results may indicate an illness or disease. The rising prevalence of chronic diseases and the increasing use of point-of-care testing are projected to be the primary drivers of market development. The term "urinary tract infection" refers to an infection that affects any portion of the urinary tract. Urinary tract infections are common in women, according to Therapeutic Advances in Urology, with a worldwide prevalence of 50 percent to 60 percent in adult women in 2019. Furthermore, an increase in the prevalence of diabetes is projected to increase demand for automated analyzers. According to the International Diabetes Federation, 429.9 million individuals worldwide were diagnosed with diabetes in 2019. As a result, the mentioned factors are expected to fuel the growth of the urinalysis market. However, availability of refurbished urine analyzers may impede market growth over the forecast period of 2021-2027.

North America, Europe, Asia Pacific, and the Rest of the World cover the worldwide urinalysis market. North America held the largest share of the worldwide urinalysis market. The growing geriatric population, implementation of favorable government policies, increasing healthcare expenditure, improved healthcare infrastructure, and the availability of technologically advanced instruments are all factors contributing to the growth of the North American urinalysis market.

Major market player included in this report are:
Beckman Coulter Inc.
Abbott Laboratories (Alere)
Becton, Dickinson and Company
Siemens Healthineers
Cardinal Health Inc.
Sysmex Corporation
Bio-Rad Laboratories Inc.
Acon Laboratories Inc.
Roche Diagnostics
Arkray Inc.




The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product type:
Instruments
Consumable
By test type :
Biochemical
Pregnancy & Fertility
Sediment
By Application:
Disease Screening
Pregnancy & Fertility
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.

Target Audience of the Global Urinalysis Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors